127 related articles for article (PubMed ID: 1387390)
1. The effect of liver macrophages on in vitro cytolytic activity of 5FU and FUdR on colon carcinoma cells: evidence of macrophage activation.
Daemen T; Regts J; Morselt H; Scherphof GL
Int J Immunopharmacol; 1992 Jul; 14(5):857-64. PubMed ID: 1387390
[TBL] [Abstract][Full Text] [Related]
2. Functional characteristics of the rat liver macrophage population after a single intravenous injection of liposome-encapsulated muramyl peptides.
Hoedemakers RM; Vossebeld PJ; Daemen T; Scherphof GL
J Immunother Emphasis Tumor Immunol; 1993 May; 13(4):252-60. PubMed ID: 8334109
[TBL] [Abstract][Full Text] [Related]
3. Maintenance of tumoricidal activity and susceptibility to reactivation of subpopulations of rat liver macrophages.
Daemen T; Veninga A; Regts J; Scherphof GL
J Immunother (1991); 1991 Jun; 10(3):200-6. PubMed ID: 1868044
[TBL] [Abstract][Full Text] [Related]
4. In vitro activation of rat liver macrophages to tumoricidal activity by free or liposome-encapsulated muramyl dipeptide.
Daemen T; Veninga A; Roerdink FH; Scherphof GL
Cancer Res; 1986 Sep; 46(9):4330-5. PubMed ID: 3731091
[TBL] [Abstract][Full Text] [Related]
5. [Antitumoral activation of rat peritoneal macrophages by muramyl dipeptide in vitro].
Reisser D; Jeannin JF; Martin F
C R Seances Acad Sci III; 1982 Nov; 295(8):485-8. PubMed ID: 6819063
[TBL] [Abstract][Full Text] [Related]
6. Differential effects of liposome-incorporation on liver macrophage activating potencies of rough lipopolysaccharide, lipid A, and muramyl dipeptide. Differences in susceptibility to lysosomal enzymes.
Daemen T; Veninga A; Dijkstra J; Scherphof G
J Immunol; 1989 Apr; 142(7):2469-74. PubMed ID: 2926140
[TBL] [Abstract][Full Text] [Related]
7. Secretion pattern of the rat liver macrophage population following activation with liposomal muramyl dipeptide in vivo and in vitro.
Hoedemakers RM; Morselt HW; Scherphof GL; Daemen T
J Immunother Emphasis Tumor Immunol; 1994 May; 15(4):265-72. PubMed ID: 8061899
[TBL] [Abstract][Full Text] [Related]
8. Endocytic and tumoricidal heterogeneity of rat liver macrophage populations.
Daemen T; Veninga A; Roerdink FH; Scherphof GL
Sel Cancer Ther; 1989; 5(4):157-67. PubMed ID: 2623381
[TBL] [Abstract][Full Text] [Related]
9. Comparative effect of muramyl dipeptide in vivo and in vitro on the tumoricidal activity of rat peritoneal macrophages.
Reisser D; Jeannin JF; Lagadec P; Martin F
J Biol Response Mod; 1985 Oct; 4(5):460-3. PubMed ID: 4078593
[TBL] [Abstract][Full Text] [Related]
10. Conditions controlling tumor cytotoxicity of rat liver macrophages mediated by liposomal muramyl dipeptide.
Daemen T; Veninga A; Roerdink FH; Scherphof GL
Biochim Biophys Acta; 1989 Apr; 991(1):145-51. PubMed ID: 2713416
[TBL] [Abstract][Full Text] [Related]
11. Synergistic activation by recombinant mouse interferon-gamma and muramyl dipeptide of tumoricidal properties in mouse macrophages.
Saiki I; Fidler IJ
J Immunol; 1985 Jul; 135(1):684-8. PubMed ID: 3923117
[TBL] [Abstract][Full Text] [Related]
12. Chemoimmunotherapy of murine liver metastases with 5-fluorouracil in combination with liposome-encapsulated muramyl dipeptide.
Daemen T; Dontje BH; Regts J; Scherphof GL
J Immunother Emphasis Tumor Immunol; 1993 Jan; 13(1):31-5. PubMed ID: 8435429
[TBL] [Abstract][Full Text] [Related]
13. Potential value of liposomes containing muramyl dipeptide for augmenting the tumoricidal activity of human alveolar macrophages.
Sone S; Tachibana K; Shono M; Ogushi F; Tsubura E
J Biol Response Mod; 1984; 3(2):185-94. PubMed ID: 6726281
[TBL] [Abstract][Full Text] [Related]
14. Modulation of pulmonary macrophage superoxide release and tumoricidal activity following activation by biological response modifiers.
Drath DB
Immunopharmacology; 1986 Oct; 12(2):117-26. PubMed ID: 3021650
[TBL] [Abstract][Full Text] [Related]
15. Lack of response of murine peritoneal macrophages to in vitro activation by muramyl dipeptide (MDP). I. Macrophage activation by MDP is species dependent.
Nagao S; Akagawa KS; Yamada K; Yagawa K; Tokunaga T; Kotani S
Microbiol Immunol; 1990; 34(3):323-35. PubMed ID: 2352499
[TBL] [Abstract][Full Text] [Related]
16. Synergistic activation by lymphokines and muramyl dipeptide of tumoricidal properties in rat alveolar macrophages.
Sone S; Fidler IJ
J Immunol; 1980 Dec; 125(6):2454-60. PubMed ID: 7430635
[TBL] [Abstract][Full Text] [Related]
17. Induction of tumoricidal macrophages and production of cytokines by synthetic muramyl dipeptide analogues.
Saiki I; Saito S; Fujita C; Ishida H; Iida J; Murata J; Hasegawa A; Azuma I
Vaccine; 1988 Jun; 6(3):238-44. PubMed ID: 2844032
[TBL] [Abstract][Full Text] [Related]
18. Activation of murine Kupffer cell tumoricidal activity by liposomes containing lipophilic muramyl dipeptide.
Phillips NC; Rioux J; Tsao MS
Hepatology; 1988; 8(5):1046-50. PubMed ID: 2971013
[TBL] [Abstract][Full Text] [Related]
19. Activation of alveolar macrophage tumoricidal activity and eradication of experimental metastases by freeze-dried liposomes containing a new lipophilic muramyl dipeptide derivative.
Phillips NC; Moras ML; Chedid L; Lefrancier P; Bernard JM
Cancer Res; 1985 Jan; 45(1):128-34. PubMed ID: 3838084
[TBL] [Abstract][Full Text] [Related]
20. Selective activation of antitumor activity of macrophages by the delivery of muramyl dipeptide using a novel polynucleotide-based carrier recognized by scavenger receptors.
Srividya S; Roy RP; Basu SK; Mukhopadhyay A
Biochem Biophys Res Commun; 2000 Feb; 268(3):772-7. PubMed ID: 10679281
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
